The Extracorporeal Membrane Oxygenation (ECMO) system is a medical innovation that improves the quality of life for patients with severe health conditions, such as chronic obstructive pulmonary disease (COPD) and asthma. A major benefit of using the EMO system is that it provides supplemental breathing air in addition to oxygen therapy. This method of delivery allows those with respiratory problems to breathe easier and longer with less effort and discomfort than they would with traditional oxygen therapy. The use of this medical device is intended to improve the quality of life for patients who are unable to breathe on their own and is done through the introduction of pressurized streams of compressed oxygen into the lungs. There are several different models of the EMO system, each based on different technologies that deliver supplemental oxygen to the lungs.
Request Free Sample Copy With Latest Insights @ https://www.coherentmarketinsights.com/insight/request-sample/947
The global ECMO system market was valued at US$ 248.2 million in 2017, and is expected to witness a CAGR of 5.3 % over the forecast period (2021 – 2028).
Increasing prevalence of cardiovascular and respiratory disorders is boosting growth of the ECMO system market. For instance, according to World Health Organization (WHO), around 31% of total global deaths was due to cardiovascular disease in 2015, which accounted to nearly 17.7 million deaths. According to European Heart Network AISBL, about 3.9 million and over 1.8 million deaths occurs every year in Europe and European Union respectively, which accounted to nearly 45% of all deaths in European Union. Moreover, growing success of ECMO system is increasing number of organ transplant surgeries across the globe which is again fostering growth of the market. For instance, according to Organ and Tissue Authority of Australian Government, the number of surgeries performed for organ transplant in 2017 were around 1,469. Moreover, according to Australia and New Zealand Organ Donation Registry around 1,400 Australians are waiting for organ transplant at any given time.
Additionally, increasing prevalence of diseases is raising demand for extracorporeal membrane oxygenation system in hospitals and surgical centers. For example, according to annual international registry by Extracorporeal Life Support Organization (ELSO), 65,171 patients received ECMO system in 2015, which increased to 98,840 patients in 2018 out of which 40,256 were neonatal, 22,952 pediatrics, and 35,632 adults.
On the basis of region, extracorporeal oxygenation system market is segmented into North America, Latin America, Europe, Africa, Asia Pacific, and Middle East. North America is leading the ECMO system market, due to presence of well-established healthcare infrastructure, increasing government funds, and reimbursement framework. Additionally, high pool of Chronic Obstructive Pulmonary Disease (COPD) and other disorders are projected to fuel market growth in this region. Furthermore, around 85 million and 49 million people were suffering from cardiovascular disease in Europe and European Union, respectively in 2015. According to Centers for Disease Control and Prevention (CDC), COPD was the third leading cause of death with more than 15 million Americans diagnosed with COPD every year in 2011. Furthermore, Asia Pacific region is expected to gain significant traction in ECMO system market, attributed by advancements in healthcare system with support of government initiatives.
Request PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/947
Industrial Partnership by the Major Players is Fueling Extracorporeal Membrane Oxygenation System Market
The global extracorporeal membrane oxygenation system market is operated by Medtronic Plc., Getinge Group, LivaNova Plc., Terumo Corporation, Xenios AG, Microsoft Scientific Co., Origen Biomedical, Eurosets S.R.L., Nipro Corporation and Alung technologies Inc. The key players are adopting collaboration and partnership for development of new products. For instance, in 2018, Medtronic Plc. collaborated with the Sayler Biomedical LLC, for the development of their product Century heart Lung machine. The partnership has made the Medtronic’s product available for customers globally. Century heart lung machine has features, such as compact and sturdy design, easy to use components and affordable price. This is projected to strengthen customer base and widen the product portfolio of Medtronic.
Detailed Segmentation:
Global Extracorporeal Membrane Oxygenation System Market, By Modality:
Arteriovenous
Venoarteial
Venovenous
Global Extracorporeal Membrane Oxygenation System Market, By Application:
Extracorporeal cardiopulmonary resuscitation
Cardiac
Respiratory
Global Extracorporeal Membrane Oxygenation System Market, By Age Group:
Neonatal
Pediatric
Adults
𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐒𝐚𝐥𝐞 𝐈𝐬 𝐋𝐢𝐯𝐞
𝐁𝐮𝐲 𝐍𝐨𝐰 𝐓𝐎 𝐀𝐯𝐚𝐢𝐥 𝐃𝐢𝐬𝐜𝐨𝐮𝐧𝐭 𝐅𝐫𝐨𝐦 𝟐𝟓-𝟑𝟎% 𝐓𝐢𝐥𝐥 𝟑𝟏-𝐃𝐞𝐜-𝟐𝟎𝟐𝟏
Buy This Complete Business Report @ https://www.coherentmarketinsights.com/insight/buy-now/947
Table of Content
Chapter 1 Industry Overview
1.1 Definition
1.2 Assumptions
1.3 Research Scope
1.4 Market Analysis by Regions
1.5 Extracorporeal Membrane Oxygenation System Market Size Analysis from 2021 to 2028
11.6 COVID-19 Outbreak: Extracorporeal Membrane Oxygenation System Industry Impact
Chapter 2 Extracorporeal Membrane Oxygenation System Competition by Types, Applications, and Top Regions and Countries
2.1 Extracorporeal Membrane Oxygenation System (Volume and Value) by Type
2.3 Extracorporeal Membrane Oxygenation System (Volume and Value) by Regions
Chapter 3 Production Market Analysis
3.1 Production Market Analysis
3.2 Regional Production Market Analysis
Chapter 4 Extracorporeal Membrane Oxygenation System Sales, Consumption, Export, Import by Regions (2016-2021)
Chapter 5 North America Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 6 East Asia Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 7 Europe Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 8 South Asia Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 9 Southeast Asia Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 10 Middle East Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 11 Africa Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 12 Oceania Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 13 South America Extracorporeal Membrane Oxygenation System Market Analysis
Chapter 14 Company Profiles and Key Figures in Extracorporeal Membrane Oxygenation System Business
Chapter 15 Extracorporeal Membrane Oxygenation System Market Forecast (2021-2027)
Chapter 16 Conclusions
Research Methodology
Continued….
Related Market Intelligence Reports:
About Us:
Coherent Market Insights is a global market intelligence and consulting organization that provides syndicated research reports, customized research reports, and consulting services. We are known for our actionable insights and authentic reports in various domains including aerospace and defense, agriculture, food and beverages, automotive, chemicals and materials, and virtually all domains and an exhaustive list of sub-domains under the sun. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837